- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02094820
Psychological Wellbeing in Chronic Fatigue Syndrome
Psychological Wellbeing in Adults With Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis
Objectives: Chronic Fatigue Syndrome (CFS) is a medically unexplained condition characterized by severe and disabling fatigue. To date much research has focused on finding out whether CFS is caused by mainly physical or psychological factors. Perhaps as a result of this, few studies have examined the relationship between CFS and quality of life, in particular, more positive aspects of mental health, such as an individual's sense of purpose, autonomy and close relationships.
This study will address these limitations by examining Ryff's (1989) six domains of psychological well-being (PWB), and other aspects of well-being including positive emotions, in CFS. It will also examine the relationship between measures of symptomology, emotional distress and PWB.
Method: This is a cross-sectional, questionnaire-based study with a clinical sample of adults with CFS. Participants will complete valid measures of well-being and symptomology.
Results: We expect to find that compared to general population norms, individuals with CFS score lower on measures of PWB. Secondly, we expect PWB dimensions will be related to symptom measures. There are however, no grounds for making strong predictions.
Implications: This study will advance our understanding of quality of life in CFS. Clinically, it has the potential to enrich and inform therapeutic interventions.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Lincolnshire, United Kingdom
- Lincolnshire Hospital Foundation Trust
-
London, United Kingdom
- Royal London Hospital for Integrated Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Chronic Fatigue Syndrome as defined by NICE (2007).
- Aged 18 or over
- English speaking
Exclusion Criteria:
- Insufficient English language skills to participate without the use of an interpreter.
- Insufficient ability to read and write independently.
- Incapacity to consent to the study as defined by the Mental Capacity Act (2005).
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
Single Group Study
Questionnaires
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ryff (1989) Scale of Psychological Well-Being (SPWB)
Time Frame: 1 time point
|
The Ryff (1989) Scale of Psychological Well-Being (SPWB) is comprised of 54 items, equally divided into 6 scales: autonomy, environmental mastery, personal growth, purpose in life, positive relations with others, and self-acceptance.
Responses are given on a scale of 1-6 (strongly disagree to strongly agree), with some items being reverse-scored.
Internal consistency is good across all scales (alpha range = 0.86- 0.93), as is test-retest reliability over a 6- week period (range = 0.81-0.88).
In terms of its convergent validity the SPWB has been found to correlate positively with other measures of positive functioning (i.e., life satisfaction, affect balance, self- esteem, internal control, and morale), with coefficients ranging from .25 to .73.
Furthermore, correlations with measures of negative functioning (i.e., powerful others, chance control, depression) have been negative and significant, with coefficients ranging from -0.30 to -0.60.
|
1 time point
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Scale of Positive and Negative Experience (SPANE; Diner, Wirtz, Tov et al., 2009)
Time Frame: 1 time point
|
a brief 12-item scale, with six items corresponding to positive emotions and six items corresponding to negative emotions.
Each item is scored on a scale ranging from 1 to 5, where 1 represents "very rarely or never" and 5 represents "very often or always."
The positive and negative scales are scored separately and each range from 6 to 30.
The two scores can also be combined as a scale of balanced affect.
Internal consistency is good (ranging from 0.81-0.89
across the scales), as is temporal stability (0.62-0.68).
The SPANE has performed well in terms of convergent validity with other measures of emotion, well-being, happiness, and life satisfaction.
|
1 time point
|
|
The Meaning in Life Questionnaire (Steger, Frazier, Oishi et al., 2006)
Time Frame: 1 time point
|
A brief 10-item questionnaire designed to measure two dimensions of meaning in life: (1) Presence of Meaning (the subjective sense that one's life is meaningful), and (2) Search for Meaning (drive and orientation toward finding meaning in one's life).
Respondents answer each item on a 7-point Likert-type scale ranging from 1 (Absolutely True) to 7 (Absolutely Untrue).
In non-clinical populations both subscales have demonstrated good internal consistency, with cronbach's alphas ranging from 0.86-0.88.
In terms of convergent validity, the Presence of Meaning subscale has been found to correlate positively with life satisfaction, positive emotions, extraversion and agreeableness.
It has also been found to correlate negative with depression, negative emotions and neuroticism.
The Search for Meaning subscale in contrast has been found to correlate positively with neuroticism, depression and several negative emotions.
|
1 time point
|
|
The Multidimensional Fatigue Inventory (MFI -20; Smets, Garssen, Bonke & Haes, 1995)
Time Frame: 1 time point
|
A 20-item self-report instrument consisting of five scales: General Fatigue, Physical Fatigue, Reduced Activity, Reduced Motivation, and Mental Fatigue.
Each scale contains four items rated on a scale of zero to 5 with the scale score of zero having the anchor of entirely true and the scale score of 5 having the anchor of no, not true.
In a CFS sample all subscales have demonstrated good internal consistency (general fatigue = 0.89; physical fatigue =0.82, mental fatigue= 0.92; reduced activity= 0.90; reduced motivation= 0.77).
|
1 time point
|
|
The Pain Visual Analog Scale (VAS; McCormack, Horne & Sheather, 1988)
Time Frame: 1 time-point
|
Assesses subjective perception of pain based on a 10-cm line (0-10, no pain to pain as bad as it could be).
It is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations, including those with rheumatic diseases.
The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity.
A higher score indicates greater pain intensity.
Based on the distribution of pain VAS scores in postsurgical patients (knee replacement, hysterectomy, or laparoscopic myomectomy) who described their postoperative pain intensity as none, mild, moderate, or severe, the following cut points on the pain VAS have been recommended: no pain (0 - 4 mm), mild pain (5- 44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm).
It takes less than 1 minute to complete (Hawker, Mian, Kendzerska & French, 2011).
|
1 time-point
|
|
The Hospital Anxiety and Depression Scale (HADS)
Time Frame: 1 time-point
|
A 14-item measures anxiety and depression in people with physical health problems, excluding items related to somatic symptoms that are higher in these populations.
It is widely used and has demonstrated good reliability and validity.
A score of above 10 on either subscale is considered clinically significant.
|
1 time-point
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hannah Jackson, Royal Holloway University London
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HJ2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Fatigue Syndrome
-
Oslo University HospitalCompletedAdolescent Chronic Fatigue SyndromeNorway
-
Shanghai University of Traditional Chinese MedicineShanghai Yueyang Integrated Medicine HospitalRecruiting
-
Ho Cheol Shin, M.D., Ph.D.Green Cross Corporation; Ajou University School of Medicine; SymyooCompletedChronic Fatigue Syndrome | Idiopathic Chronic FatigueKorea, Republic of
-
King Saud UniversityCompletedChronic Fatigue Syndrome (CFS)
-
Stony Brook UniversityCompletedChronic Fatigue Syndrome | Medically Unexplained Chronic FatigueUnited States
-
AIM ImmunoTech Inc.Temporarily not available
-
Center for Health Sciences, SerbiaActive, not recruitingChronic Fatigue Syndrome
-
Power Life Sciences Inc.Not yet recruitingChronic Fatigue SyndromeUnited States
-
University of SevilleActive, not recruitingPost COVID Syndrome | Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)Spain
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting